Global Helicobacter Pylori Tester Without Endoscopy Market Size By Type (Stool/fecal Antigen Test, Urea breath test), By Application (Hospitals, Private Labs), By Region, And Segment Forecasts, 2023 t...

The Global Helicobacter Pylori Tester Without Endoscopy Market was valued at USD 485 million in 2023 and is projected to surpass USD 894 million by 2031, growing at a CAGR of 7.9% during the forecast period from 2023 to 2031. The market growth is driven by the increasing prevalence of H. pylori infections, rising demand for non-invasive diagnostic methods, and the growing preference for rapid testing across clinical settings. Helicobacter pylori, a common cause of peptic ulcers and gastric cancer, can be diagnosed effectively through urea breath tests, stool antigen tests, and serological assays—eliminating the need for invasive procedures like endoscopy.

Drivers:

1. Rising Prevalence of H. Pylori Infections: The global burden of H. pylori is substantial, particularly in low- and middle-income countries. With increasing awareness and early detection initiatives, there is a growing need for accessible, accurate, and non-invasive diagnostic tools.

2. Shift Toward Non-Invasive Testing: Conventional endoscopy is often uncomfortable, expensive, and resource-intensive. In contrast, breath and stool-based tests offer painless and quick diagnostic alternatives, driving their adoption in outpatient and point-of-care settings.

3. Technological Advancements in Diagnostic Tools: Improvements in breath analyzer sensitivity, integration with digital platforms, and development of home testing kits are making these tests more reliable and widely accessible.

Restraints:

1. Limited Accuracy in Some Non-Invasive Methods: While convenient, certain non-invasive tests may yield false positives or negatives, especially in recently treated patients or those taking medications that suppress H. pylori, affecting diagnostic accuracy.

2. Low Awareness in Underdeveloped Markets: Despite the availability of non-invasive diagnostics, their adoption is hampered by insufficient healthcare infrastructure and limited awareness, particularly in rural or economically constrained regions.

Opportunity:

1. Growth in Home Testing Solutions: Rising interest in at-home diagnostics post-COVID-19 presents opportunities for market players to expand their offerings with accurate, user-friendly kits for H. pylori detection.

2. Expansion into Emerging Economies: Improved healthcare access and government-supported screening programs in Asia-Pacific, Latin America, and parts of Africa are opening new avenues for growth in the H. pylori tester market.

Market by System Type Insights:

Among various system types, Urea Breath Test Kits led the market in 2023, owing to their high sensitivity and ease of use in detecting active infections. These tests provide rapid results with minimal discomfort, making them the preferred option in clinical practices. Stool Antigen Test Kits are also gaining traction due to their applicability in pediatric cases and in regions where breath analyzers are less accessible.

Market by End-Use Insights:

In 2023, the Hospitals and Clinics segment accounted for the largest share of the market, as these facilities remain the primary centers for diagnosis and treatment of gastrointestinal infections. However, the Homecare segment is expected to witness the fastest growth during the forecast period, driven by increasing consumer preference for remote healthcare and advancements in self-diagnostic tools.

Market by Regional Insights:

North America held the largest market share in 2023, driven by a well-established healthcare system, widespread screening programs, and high awareness of gastrointestinal health. Asia-Pacific is projected to experience the highest growth rate due to the region’s large population base, rising infection prevalence, and expanding access to healthcare diagnostics in countries like India and China.

Competitive Scenario:

Leading players in the Global Helicobacter Pylori Tester Without Endoscopy Market include Thermo Fisher Scientific Inc., Sekisui Diagnostics, Abbott Laboratories, DiaSorin S.p.A., Meridian Bioscience, Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd., and Exalenz Bioscience Ltd. These companies focus on strategic collaborations, new product development, and geographic expansion to strengthen their market presence.

Recent Developments:

In 2023, Thermo Fisher launched an AI-integrated urea breath test analyzer with improved accuracy and reporting efficiency.

In 2024, DiaSorin S.p.A. received regulatory clearance in Europe for its next-generation stool antigen testing kit with a shorter turnaround time.

Abbott expanded its rapid diagnostic portfolio in 2023 to include a home-based H. pylori breath test, designed for ease of use and telehealth integration.

Scope of Work – Global Helicobacter Pylori Tester Without Endoscopy Market

Report Metric Details

Market Size (2023) USD 485 million

Projected Market Size (2031) USD 894 million

CAGR (2023-2031) 7.9%

Market Segments By System Type (Urea Breath Test Kits, Stool Antigen Test Kits, Others),

By End-Use (Hospitals & Clinics, Diagnostic Laboratories, Homecare)

Growth Drivers Rising H. pylori prevalence, demand for non-invasive testing, tech advancements

Opportunities Expansion in emerging markets, rise in home diagnostics

FAQs:

1) What is the current market size of the Global Helicobacter Pylori Tester Without Endoscopy Market?

The market was valued at USD 485 million in 2023.

2) What is the major growth driver of the Global Helicobacter Pylori Tester Without Endoscopy Market?

The major driver is the increasing demand for non-invasive, accurate, and rapid diagnostic solutions.

3) Which is the largest region during the forecast period in the Global Helicobacter Pylori Tester Without Endoscopy Market?

North America is the largest region, with significant adoption of advanced diagnostics.

4) Which segment accounted for the largest market share in the Global Helicobacter Pylori Tester Without Endoscopy Market?

The Urea Breath Test Kits segment held the largest share in 2023.

5) Who are the key market players in the Global Helicobacter Pylori Tester Without Endoscopy Market?

Key players include Thermo Fisher Scientific Inc., Sekisui Diagnostics, Abbott Laboratories, DiaSorin S.p.A., and Meridian Bioscience.